$VTAK Catheter Precision, Inc. (NYSE American: VTA
Post# of 91
(Total Views: 102)
Posted On: 03/11/2024 9:33:06 AM
$VTAK Catheter Precision, Inc. (NYSE American: VTAK) Announces the First use of LockeT Outside of the United States
https://www.accesswire.com/841419/catheter-pr...ted-states
FORT MILL, SC / ACCESSWIRE / March 11, 2024 / Catheter Precision, Inc. (the "Company"
(NYSE American:VTAK), a US based medical device company focused on electrophysiology products, announced that LockeT was used for the first time outside of the United States at Hamad Medical Corporation Heart Hospital in Doha, Qatar. Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East. HMC manages 12 hospitals - nine specialist hospitals and three community hospitals.
After using LockeT, Dr. Sajad Hayat said, "A vascular hemostasis [product] should be simple to use and effective. The LockeT venous hemostasis device combines the simplicity of a figure of 8 suture but with a more controlled delivery and release making it ideal. Importantly, it simplifies post procedure care facilitating early mobilization and discharge."
"Not only were the first cases outside of the United States successful, but the value of the product was immediately observed by the physician," said David Jenkins, CEO of Catheter Precision, Inc. "Dr. Hayat was quick to observe that LockeT is not only simple in design, but simple to use and that it effectively creates hemostasis and provides additional benefits to the patient and hospital staff."
https://www.accesswire.com/841419/catheter-pr...ted-states
FORT MILL, SC / ACCESSWIRE / March 11, 2024 / Catheter Precision, Inc. (the "Company"
(NYSE American:VTAK), a US based medical device company focused on electrophysiology products, announced that LockeT was used for the first time outside of the United States at Hamad Medical Corporation Heart Hospital in Doha, Qatar. Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East. HMC manages 12 hospitals - nine specialist hospitals and three community hospitals. After using LockeT, Dr. Sajad Hayat said, "A vascular hemostasis [product] should be simple to use and effective. The LockeT venous hemostasis device combines the simplicity of a figure of 8 suture but with a more controlled delivery and release making it ideal. Importantly, it simplifies post procedure care facilitating early mobilization and discharge."
"Not only were the first cases outside of the United States successful, but the value of the product was immediately observed by the physician," said David Jenkins, CEO of Catheter Precision, Inc. "Dr. Hayat was quick to observe that LockeT is not only simple in design, but simple to use and that it effectively creates hemostasis and provides additional benefits to the patient and hospital staff."
(0)
(0)Ra Medical Systems Inc. (RMED) Stock Research Links
Scroll down for more posts ▼